Total Payments
$391,947
2024 Payments
$34,486
Companies
7
Transactions
240
Medicare Patients
780
Medicare Billing
$137,151
Payment Breakdown by Category
Consulting$288,751 (73.7%)
Other$86,608 (22.1%)
Travel$12,091 (3.1%)
Food & Beverage$4,390 (1.1%)
Education$94.96 (0.0%)
Gifts$11.97 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $288,751 | 21 | 73.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $86,608 | 46 | 22.1% |
| Travel and Lodging | $12,091 | 51 | 3.1% |
| Food and Beverage | $4,390 | 118 | 1.1% |
| Education | $94.96 | 3 | 0.0% |
| Gift | $11.97 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $240,535 | 52 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $63,720 | 65 | $0 (2023) |
| United Therapeutics Corporation | $61,106 | 83 | $0 (2024) |
| Gilead Sciences, Inc. | $15,641 | 23 | $0 (2019) |
| Merck Sharp & Dohme LLC | $10,893 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $40.34 | 1 | $0 (2022) |
| TETRAPHASE PHARMACEUTICALS, INC. | $11.97 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34,486 | 49 | United Therapeutics Corporation ($27,567) |
| 2023 | $224,959 | 27 | Actelion Pharmaceuticals US, Inc. ($193,841) |
| 2022 | $53,553 | 24 | Actelion Pharmaceuticals US, Inc. ($27,631) |
| 2021 | $4,128 | 4 | United Therapeutics Corporation ($2,540) |
| 2020 | $11,704 | 12 | United Therapeutics Corporation ($8,530) |
| 2019 | $9,493 | 20 | Bayer HealthCare Pharmaceuticals Inc. ($7,644) |
| 2018 | $27,197 | 50 | Actelion Pharmaceuticals US, Inc. ($12,163) |
| 2017 | $26,426 | 54 | Bayer HealthCare Pharmaceuticals Inc. ($12,294) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $5,490.00 | General |
| 12/09/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 11/15/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $580.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $220.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $64.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $51.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $34.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $220.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,270.00 | General |
| 10/09/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $33.89 | General |
| 10/08/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,270.00 | General |
| 10/08/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $32.00 | General |
| 10/07/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $3.10 | General |
| 08/19/2024 | United Therapeutics Corporation | REMODULIN (Drug), ORENITRAM | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 08/08/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $216.39 | General |
| 08/08/2024 | United Therapeutics Corporation | — | Food and Beverage | Cash or cash equivalent | $126.10 | General |
| 08/08/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $50.79 | General |
| 08/08/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $36.23 | General |
| 08/08/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $36.00 | General |
| 08/08/2024 | United Therapeutics Corporation | — | Food and Beverage | Cash or cash equivalent | $27.61 | General |
| 08/08/2024 | United Therapeutics Corporation | — | Food and Beverage | Cash or cash equivalent | $19.41 | General |
| 06/27/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $235.84 | General |
| 06/26/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| 06/20/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $102.58 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 197 | 297 | $297,299 | $32,311 |
| 2022 | 7 | 154 | 233 | $219,340 | $26,785 |
| 2021 | 7 | 193 | 311 | $321,893 | $39,803 |
| 2020 | 8 | 236 | 350 | $321,526 | $38,252 |
Total Patients
780
Total Services
1,191
Medicare Billing
$137,151
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 63 | 124 | $205,716 | $20,554 | 10.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 29 | 55 | $32,250 | $5,488 | 17.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 30 | $18,692 | $2,749 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 18 | $7,422 | $1,048 | 14.1% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 15 | 15 | $14,010 | $943.38 | 6.7% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2023 | 13 | 13 | $6,708 | $630.35 | 9.4% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 14 | 15 | $6,270 | $517.20 | 8.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 12 | 12 | $4,596 | $228.00 | 5.0% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 14 | 15 | $1,635 | $154.43 | 9.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 55 | 98 | $147,784 | $17,082 | 11.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 31 | 49 | $26,220 | $5,148 | 19.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 24 | $13,272 | $1,906 | 14.4% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 12 | 17 | $14,433 | $1,133 | 7.9% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 15 | 20 | $7,600 | $645.06 | 8.5% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2022 | 11 | 11 | $5,159 | $594.33 | 11.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 12 | 14 | $4,872 | $276.22 | 5.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 76 | 164 | $247,312 | $29,200 | 11.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 30 | 50 | $25,990 | $5,094 | 19.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 38 | $20,406 | $3,119 | 15.3% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2021 | 14 | 14 | $6,566 | $759.08 | 11.6% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 11 | 11 | $9,339 | $748.11 | 8.0% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 14 | 14 | $5,320 | $482.76 | 9.1% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2021 | 19 | 20 | $6,960 | $399.80 | 5.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 77 | 150 | $226,200 | $26,464 | 11.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 40 | 53 | $27,613 | $4,293 | 15.5% |
About Dr. Neal Chaisson, MD
Dr. Neal Chaisson, MD is a Pulmonary Disease healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1932373826.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Neal Chaisson, MD has received a total of $391,947 in payments from pharmaceutical and medical device companies, with $34,486 received in 2024. These payments were reported across 240 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($288,751).
As a Medicare-enrolled provider, Chaisson has provided services to 780 Medicare beneficiaries, totaling 1,191 services with total Medicare billing of $137,151. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Cleveland, OH
- Active Since 04/22/2008
- Last Updated 04/06/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1932373826
Products in Payments
- UPTRAVI (Drug) $190,662
- Adempas (Drug) $63,720
- OPSUMIT (Drug) $30,890
- OPSUMIT MACITENTAN (Drug) $5,280
- ORENITRAM (Drug) $1,209
- WINREVAIR (Biological) $1,171
- Letairis (Drug) $283.91
- TYVASO (Drug) $95.69
- DUPIXENT (Biological) $40.34
- ZERBAXA (Drug) $36.51
- Xerava (Drug) $11.97
- REMODULIN (Drug) $11.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Cleveland
Michael Machuzak, M.d, M.D
Pulmonary Disease — Payments: $363,191
Pulmonary Disease $363,191
Dr. Joseph Cicenia, Md, MD
Pulmonary Disease — Payments: $244,813
Pulmonary Disease $244,813
Daniel Culver, Do, DO
Pulmonary Disease — Payments: $140,353
Pulmonary Disease $140,353
Dr. Tanmay Panchabhai, Md, MD
Pulmonary Disease — Payments: $124,047
Pulmonary Disease $124,047
Marie Budev, Do, DO
Pulmonary Disease — Payments: $115,031
Pulmonary Disease $115,031
James Stoller, M.d, M.D
Pulmonary Disease — Payments: $113,420
Pulmonary Disease $113,420